News
MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...
The Lee Health Heart Institute is thrilled to present the health system’s highest number of abstracts accepted for the second year in a row at the prestigious American College of Cardiology (ACC) ...
New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, ...
6d
HealthDay on MSNMitral Annular Disjunction Linked to Increased Risk for Ventricular Arrhythmias After SurgeryFor patients with mitral valve prolapse (MVP) and mitral regurgitation (MR), mitral annular disjunction (MAD) is associated ...
as well as reduced early diastolic mitral annular velocity using tissue Doppler imaging. In late stages with LV failure associated with elevations in left atrial pressure, a so-called restrictive ...
People with a certain heart valve abnormality may be at an increased risk of developing severe heart rhythm disorders also ...
Mitral annular disjunction, MAD, is a heart abnormality in which the mitral valve attachment 'slides'. In recent years, the condition has been linked to an increased risk of severe cardiac arrhythmias ...
After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...
This is according to a new study, "Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery" from Karolinska Institutet and Karolinska ...
Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery. European Heart Journal , 2025; DOI: 10.1093/eurheartj/ehaf195 Cite This Page : ...
Mitral annular disjunction, MAD, is a heart abnormality in which the mitral valve attachment 'slides'. In recent years, the condition has been linked to an increased risk of severe cardiac ...
Edwards is building a multi-product TMTT portfolio. The company received CE marks for its Pascal mitral and tricuspid valve repair devices in 2019 and 2020, respectively, and for the Evoque tricuspid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results